Compositions and methods for the depletion of cd117+ cells
US-2024360238-A1 · Oct 31, 2024 · US
Glanville Jacob is listed as an inventor on 10 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Glanville Jacob |
| Total patents | 10 |
| First publication | Nov 26, 2015 |
| Latest publication | Oct 31, 2024 |
Publications ranked by popularity score, then publication date.
US-2024360238-A1 · Oct 31, 2024 · US
US-11958908-B2 · Apr 16, 2024 · US
US-2022281989-A1 · Sep 8, 2022 · US
US-11407837-B2 · Aug 9, 2022 · US
US-2021206872-A1 · Jul 8, 2021 · US
US-10899843-B2 · Jan 26, 2021 · US
US-2019153114-A1 · May 23, 2019 · US
US-2019135926-A1 · May 9, 2019 · US
US-10202640-B2 · Feb 12, 2019 · US
US-2015337369-A1 · Nov 26, 2015 · US
Latest publications not already listed above.
No data yet.
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Magenta Therapeutics Inc | 3 |
| Twist Bioscience Corp | 3 |
| Crispr Therapeutics Ag | 2 |
| Univ Leland Stanford Junior | 2 |
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| A61K2039/505 | 8 |
| C07K16/2896 | 5 |
| C07K2317/71 | 5 |
| C07K16/2803 | 5 |
| A61K47/6817 | 5 |